Benzinga | Aug 9, 2021 04:47PM EDT

Exagen Q2 EPS $(0.38) Beats $(0.44) Estimate, Sales $12.80M Beat $11.48M Estimate

Exagen (NASDAQ:XGN) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.44) by 13.64 percent. This is a 40.74 percent decrease over losses of $(0.27) per share from the same period last year. The company reported quarterly sales of $12.80 million which beat the analyst consensus estimate of $11.48 million by 11.50 percent. This is a 43.05 percent increase over sales of $8.95 million the same period last year.